The rationale for high ICI resistance is related primarily to the mutations of apoptosis-regulated genes such as TP53 and RB1 (especially in the case of MCPyV-negative MCC) but also due to the overexpression of anti-apoptotic proteins like Bcl-2 and Bcl-xl [113]. This evidence concerns the gene BCL2 and Merkel cell skin cancer.